v3.25.1
Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Feb. 28, 2025
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2022
Summary of Significant Accounting Policies [Line Items]            
Other income   $ 3,556 $ 3,556  
Redemption price per share (in Dollars per share)   $ 2   $ 2    
Conversion of the outstanding preferred stock (in Shares)     19,887,616      
Common stock outstanding (in Shares)     19,181,066      
Common stock issuable upon conversion   $ 19,887,616      
Deferred offering cost       878  
Recognized income tax percentage       50.00%    
Unrecognized tax benefits        
Additional shares (in Shares) 150,000          
Patents [Member]            
Summary of Significant Accounting Policies [Line Items]            
Estimated useful life       20 years    
Mabwell (Shanghai) Bioscience Co Ltd [Member]            
Summary of Significant Accounting Policies [Line Items]            
Receivables           $ 3,500
Other income     $ 3,500 $ 3,500    
Contingent Earnout Shares [Member]            
Summary of Significant Accounting Policies [Line Items]            
Additional shares (in Shares)       14,500,000    
AbMed [Member]            
Summary of Significant Accounting Policies [Line Items]            
Ownership interest   82.00%   82.00%